急性运动感觉轴索神经病伴眼麻痹的异常表型,以及抗- GD1a, - GD1b和- GM1抗体

Q4 Immunology and Microbiology Clinical and Experimental Neuroimmunology Pub Date : 2022-04-30 DOI:10.1111/cen3.12704
Theodora Afrantou, Vasilios Kimiskidis, Roza Lagoudaki, Thomai Stardeli, Vasileios Papaliagkas, Georgia Zafeiridou, Giannoula Thoma, Zoi Aidoni, Nikolaos Grigoriadis
{"title":"急性运动感觉轴索神经病伴眼麻痹的异常表型,以及抗- GD1a, - GD1b和- GM1抗体","authors":"Theodora Afrantou,&nbsp;Vasilios Kimiskidis,&nbsp;Roza Lagoudaki,&nbsp;Thomai Stardeli,&nbsp;Vasileios Papaliagkas,&nbsp;Georgia Zafeiridou,&nbsp;Giannoula Thoma,&nbsp;Zoi Aidoni,&nbsp;Nikolaos Grigoriadis","doi":"10.1111/cen3.12704","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Acute motor sensory axonal neuropathy (AMSAN) is a severe form of Guillain–Barré syndrome, which typically is not related to ocular palsy, and is pathologically associated with antibodies against GM1 and GD1a gangliosides.</p>\n </section>\n \n <section>\n \n <h3> Case presentation</h3>\n \n <p>We present a patient with a severe, drug-resistant form of AMSAN with ophthalmoplegia related to antiganglioside (anti-GD1a, -GD1b, -GM1) antibodies in the serum and cerebrospinal fluid, and with a poor long-term outcome.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Rare cases of AMSAN with ophthalmoplegia are described in the literature. The present patient is a case of an unusual clinical phenotype of AMSAN, the characteristics of which warn of a serious clinical course that requires timely aggressive treatment.</p>\n </section>\n </div>","PeriodicalId":10193,"journal":{"name":"Clinical and Experimental Neuroimmunology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Unusual phenotype of acute motor sensory axonal neuropathy with ophthalmoplegia, and anti-GD1a, -GD1b and -GM1 antibodies\",\"authors\":\"Theodora Afrantou,&nbsp;Vasilios Kimiskidis,&nbsp;Roza Lagoudaki,&nbsp;Thomai Stardeli,&nbsp;Vasileios Papaliagkas,&nbsp;Georgia Zafeiridou,&nbsp;Giannoula Thoma,&nbsp;Zoi Aidoni,&nbsp;Nikolaos Grigoriadis\",\"doi\":\"10.1111/cen3.12704\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Acute motor sensory axonal neuropathy (AMSAN) is a severe form of Guillain–Barré syndrome, which typically is not related to ocular palsy, and is pathologically associated with antibodies against GM1 and GD1a gangliosides.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Case presentation</h3>\\n \\n <p>We present a patient with a severe, drug-resistant form of AMSAN with ophthalmoplegia related to antiganglioside (anti-GD1a, -GD1b, -GM1) antibodies in the serum and cerebrospinal fluid, and with a poor long-term outcome.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Rare cases of AMSAN with ophthalmoplegia are described in the literature. The present patient is a case of an unusual clinical phenotype of AMSAN, the characteristics of which warn of a serious clinical course that requires timely aggressive treatment.</p>\\n </section>\\n </div>\",\"PeriodicalId\":10193,\"journal\":{\"name\":\"Clinical and Experimental Neuroimmunology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-04-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Neuroimmunology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/cen3.12704\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Immunology and Microbiology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Neuroimmunology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cen3.12704","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 0

摘要

急性运动感觉轴索神经病变(AMSAN)是吉兰-巴罗综合征的一种严重形式,通常与眼性麻痹无关,并且在病理上与针对GM1和GD1a神经节苷脂的抗体相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Unusual phenotype of acute motor sensory axonal neuropathy with ophthalmoplegia, and anti-GD1a, -GD1b and -GM1 antibodies

Background

Acute motor sensory axonal neuropathy (AMSAN) is a severe form of Guillain–Barré syndrome, which typically is not related to ocular palsy, and is pathologically associated with antibodies against GM1 and GD1a gangliosides.

Case presentation

We present a patient with a severe, drug-resistant form of AMSAN with ophthalmoplegia related to antiganglioside (anti-GD1a, -GD1b, -GM1) antibodies in the serum and cerebrospinal fluid, and with a poor long-term outcome.

Conclusions

Rare cases of AMSAN with ophthalmoplegia are described in the literature. The present patient is a case of an unusual clinical phenotype of AMSAN, the characteristics of which warn of a serious clinical course that requires timely aggressive treatment.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical and Experimental Neuroimmunology
Clinical and Experimental Neuroimmunology Immunology and Microbiology-Immunology and Microbiology (miscellaneous)
CiteScore
1.60
自引率
0.00%
发文量
52
期刊最新文献
Issue Information Longitudinal imaging for monitoring disease activity in late‐onset Rasmussen's encephalitis during multimodal rehabilitation and immune therapy Response to: Eculizumab use throughout pregnancy in two patients with aquaporin‐4‐positive neuromyelitis optica spectrum disorder Th17 pathway‐related immune signatures in the pathobiology of myasthenia gravis: Integrating the roles of regulatory/effector cytokines and transcription factors Successful treatment with plasmapheresis of severe Bickerstaff brainstem encephalitis with high cerebrospinal fluid CXCL‐10 levels after COVID‐19 infection: A case report
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1